Skip to main content
Top
Published in: Diabetologia 6/2005

01-06-2005 | Article

Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain

Authors: G. Bienvenu, D. Seurin, Y. Le Bouc, P. Even, S. Babajko, C. Magnan

Published in: Diabetologia | Issue 6/2005

Login to get access

Abstract

Aims/hypothesis

IGFs, IGF receptors and IGF binding proteins (IGFBPs) are widely expressed in the central nervous system. To investigate the physiological significance of IGFBP-6 in the brain we established two transgenic mouse lines overexpressing human (h)-IGFBP-6 under the control of glial fibrillary acidic protein promoter. Increasing evidence suggests that insulin/IGF signalling pathways could be implicated in the neuroendocrine regulation of energy homeostasis. We explored the impact of brain IGFBP-6 overexpression on the regulation of food intake and energy balance.

Methods

Transgenic mice were fed either a control diet or a high-fat diet for up to 3 months. Glucose and insulin tolerance tests were carried out before and after the diet period. Plasma parameters (insulin, leptin, glucose, NEFAs and triglycerides) were measured, and uncoupling protein 1 (UCP-1) expression was quantified in brown adipose tissue. Oxygen consumption was also measured in both groups.

Results

The transgenic mice fed a high-fat diet for 3 months developed obesity, showing increases in plasma leptin, glucose and insulin levels and mild insulin resistance. As compared with wild-type mice, no significant differences were found in the quantity of food intake. However, UCP-1 expression was down-regulated in the brown adipose tissue of the transgenic mice.

Conclusions/interpretation

Our results show that brain IGFBP-6 has an impact on the regulation of energy homeostasis. These transgenic h-IGFBP-6 mice may be considered a new tool for studies of the involvement of the brain IGF system in metabolism control and obesity.
Literature
1.
go back to reference Baxter RC (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967–E976PubMed Baxter RC (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967–E976PubMed
2.
go back to reference Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45–62CrossRefPubMed Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45–62CrossRefPubMed
3.
go back to reference Shimasaki S, Ling N (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243–266CrossRefPubMed Shimasaki S, Ling N (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243–266CrossRefPubMed
4.
go back to reference Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854CrossRefPubMed Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854CrossRefPubMed
5.
go back to reference Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761–787CrossRefPubMed Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761–787CrossRefPubMed
6.
go back to reference Miyake H, Nelson C, Rennie PS, Gleave ME (2000) Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 141:2257–2265CrossRefPubMed Miyake H, Nelson C, Rennie PS, Gleave ME (2000) Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 141:2257–2265CrossRefPubMed
7.
go back to reference Grellier P, De Galle B, Babajko S (1998) Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 58:1670–1676PubMed Grellier P, De Galle B, Babajko S (1998) Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 58:1670–1676PubMed
8.
go back to reference Bach LA (1999) Insulin-like growth factor binding protein-6: the ‘forgotten’ binding protein? Horm Metab Res 31:226–234PubMed Bach LA (1999) Insulin-like growth factor binding protein-6: the ‘forgotten’ binding protein? Horm Metab Res 31:226–234PubMed
9.
go back to reference D’Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G (1996) The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227–255PubMed D’Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G (1996) The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227–255PubMed
10.
go back to reference D’Ercole AJ, Ye P, O’Kusky JR (2002) Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209–220CrossRefPubMed D’Ercole AJ, Ye P, O’Kusky JR (2002) Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209–220CrossRefPubMed
11.
go back to reference Werther GA, Russo V, Baker N, Butler G (1998) The role of the insulin-like growth factor system in the developing brain. Horm Res 49(Suppl 1):37–40CrossRef Werther GA, Russo V, Baker N, Butler G (1998) The role of the insulin-like growth factor system in the developing brain. Horm Res 49(Suppl 1):37–40CrossRef
12.
go back to reference Ayer-le Lievre C, Stahlbom PA, Sara VR (1991) Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development 111:105–115PubMed Ayer-le Lievre C, Stahlbom PA, Sara VR (1991) Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development 111:105–115PubMed
13.
go back to reference Rotwein P, Burgess SK, Milbrandt JD, Krause JE (1988) Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci U S A 85:265–269PubMed Rotwein P, Burgess SK, Milbrandt JD, Krause JE (1988) Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci U S A 85:265–269PubMed
14.
go back to reference Torres-Aleman I, Pons S, Arevalo MA (1994) The insulin-like growth factor I system in the rat cerebellum: developmental regulation and role in neuronal survival and differentiation. J Neurosci Res 39:117–126CrossRefPubMed Torres-Aleman I, Pons S, Arevalo MA (1994) The insulin-like growth factor I system in the rat cerebellum: developmental regulation and role in neuronal survival and differentiation. J Neurosci Res 39:117–126CrossRefPubMed
15.
go back to reference McKelvie PA, Rosen KM, Kinney HC, Villa-Komaroff L (1992) Insulin-like growth factor II expression in the developing human brain. J Neuropathol Exp Neurol 51:464–471PubMed McKelvie PA, Rosen KM, Kinney HC, Villa-Komaroff L (1992) Insulin-like growth factor II expression in the developing human brain. J Neuropathol Exp Neurol 51:464–471PubMed
17.
go back to reference Galou M, Pournin S, Ensergueix D et al (1994) Normal and pathological expression of GFAP promoter elements in transgenic mice. Glia 12:281–293CrossRefPubMed Galou M, Pournin S, Ensergueix D et al (1994) Normal and pathological expression of GFAP promoter elements in transgenic mice. Glia 12:281–293CrossRefPubMed
18.
go back to reference Bienvenu G, Seurin D, Grellier P et al (2004) IGFBP-6 transgenic mice: post-natal growth, brain development and reproduction abnormalities. Endocrinology 145:2412–2420CrossRefPubMed Bienvenu G, Seurin D, Grellier P et al (2004) IGFBP-6 transgenic mice: post-natal growth, brain development and reproduction abnormalities. Endocrinology 145:2412–2420CrossRefPubMed
19.
go back to reference Burks DJ, de Mora JF, Schubert M et al (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377–382CrossRefPubMed Burks DJ, de Mora JF, Schubert M et al (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377–382CrossRefPubMed
20.
go back to reference Withers DJ (2001) Insulin receptor substrate proteins and neuroendocrine function. Biochem Soc Trans 29:525–529CrossRefPubMed Withers DJ (2001) Insulin receptor substrate proteins and neuroendocrine function. Biochem Soc Trans 29:525–529CrossRefPubMed
21.
go back to reference Carvalheira JB, Ribeiro EB, Araujo EP et al (2003) Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 46:1629–1640CrossRefPubMed Carvalheira JB, Ribeiro EB, Araujo EP et al (2003) Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 46:1629–1640CrossRefPubMed
22.
go back to reference Bruning JC, Gautam D, Burks DJ et al (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122–2125CrossRefPubMed Bruning JC, Gautam D, Burks DJ et al (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122–2125CrossRefPubMed
23.
go back to reference Even P, Mokhtarian A, Pele A (1994) Practical aspects of indirect calorimetry in laboratory animals. Neurosci Biobehav Rev 18:435–447CrossRefPubMed Even P, Mokhtarian A, Pele A (1994) Practical aspects of indirect calorimetry in laboratory animals. Neurosci Biobehav Rev 18:435–447CrossRefPubMed
24.
go back to reference Guma FCR, Mello TG, Mermelstein CS et al (2001) Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. Biochem Cell Biol 79:409–417CrossRefPubMed Guma FCR, Mello TG, Mermelstein CS et al (2001) Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. Biochem Cell Biol 79:409–417CrossRefPubMed
25.
go back to reference Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP (1995) Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 136:5718–5724CrossRefPubMed Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP (1995) Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 136:5718–5724CrossRefPubMed
26.
go back to reference Foster LA, Ames NK, Emery RS (1991) Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol Behav 50:745–749CrossRefPubMed Foster LA, Ames NK, Emery RS (1991) Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol Behav 50:745–749CrossRefPubMed
27.
go back to reference Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM (1988) Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11:107–111CrossRefPubMed Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM (1988) Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11:107–111CrossRefPubMed
28.
go back to reference Klein J, Fasshauer M, Benito M, Kahn CR (2000) Insulin and the beta3-adrenoceptor differentially regulate uncoupling protein-1 expression. Mol Endocrinol 14:764–773CrossRefPubMed Klein J, Fasshauer M, Benito M, Kahn CR (2000) Insulin and the beta3-adrenoceptor differentially regulate uncoupling protein-1 expression. Mol Endocrinol 14:764–773CrossRefPubMed
29.
go back to reference Rohner-Jeanrenaud F (2000) Hormonal regulation of energy partitioning. Int J Obes Relat Metab Disord 24 (Suppl 2):S4–S7CrossRefPubMed Rohner-Jeanrenaud F (2000) Hormonal regulation of energy partitioning. Int J Obes Relat Metab Disord 24 (Suppl 2):S4–S7CrossRefPubMed
30.
go back to reference Huppertz C, Fischer BM, Kim YB et al (2001) Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism. J Biol Chem 276:12520–12529CrossRefPubMed Huppertz C, Fischer BM, Kim YB et al (2001) Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism. J Biol Chem 276:12520–12529CrossRefPubMed
Metadata
Title
Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain
Authors
G. Bienvenu
D. Seurin
Y. Le Bouc
P. Even
S. Babajko
C. Magnan
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1767-6

Other articles of this Issue 6/2005

Diabetologia 6/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.